EFFICACY OF NIVOLUMAB (NWO) DURING 2+ LINE TREATMENT AND QUALITY OF LIFE IN PATIENTS WITH ADVANCED REFRACTORY NON-SMALL CELL LUNG CANCER: INTERIM RESULTS OF PROSPECTIVE OBSERVATIONAL STUDY. Вопр. онкол. [Internet]. 2019 Jan. 1 [cited 2026 Oct. 15];65(1):99-105. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/931